Pharmaceuticals

Global Lumbosacral Radicular Pain Industry Trends and Market Forecast 2026–2030

February 16, 2026February 16, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the lumbosacral radicular pain market from 2026–2035 with trusted insights from The Business Research Company

Starting from its 2026 valuation, what market size is the Lumbosacral Radicular Pain Market expected to reach by 2030?

The lumbosacral radicular pain market has experienced significant expansion in recent years. It is projected to grow from $0.97 billion in 2025 to $1.02 billion in 2026, at a compound annual growth rate (CAGR) of 6.0%. This historical market development can be ascribed to elements such as an aging population, the prevalence of spinal degenerative disorders, practices in opioid-based pain management, the establishment of hospital pain clinics, and the volumes of orthopedic surgery conducted.

The lumbosacral radicular pain market is projected to experience robust expansion over the coming years. By 2030, its valuation is anticipated to reach $1.28 billion, progressing at a compound annual growth rate (CAGR) of 5.7%. This anticipated growth during the forecast timeframe is attributable to factors such as the embrace of non-opioid pain therapies, an increase in outpatient pain procedures, the integration of digital pain monitoring tools, advancements in minimally invasive spine technologies, and the broadening of rehabilitation programs. Key trends shaping the forecast period encompass a surge in multimodal pain management approaches, the expansion of interventional spine procedures, a heightened demand for non-opioid treatments, the widening scope of rehabilitation-focused care, and the uptake of minimally invasive pain solutions.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24591&type=smp

What Drivers Are Driving Adoption Within The Lumbosacral Radicular Pain Market?

The growing occurrence of degenerative spinal conditions is projected to boost the lumbosacral radicular pain market in the future. These conditions are characterized by the spine’s gradual deterioration over time. The increase in degenerative spinal conditions stems from aging demographics and lifestyle choices that heighten the risk of spinal wear and nerve impingement, consequently elevating the need for diagnosis and therapeutic interventions. Lumbosacral radicular pain serves as an indicator for underlying degenerative spinal issues by signaling nerve root irritation or compression, thereby guiding clinical assessment and treatment strategies. For instance, in May 2023, the University of Sydney, an Australia-based public university, predicted that more than 800 million individuals globally will experience back discomfort by 2050. Consequently, the rising incidence of degenerative spinal conditions is a key driver for the expansion of the lumbosacral radicular pain market. The escalating rate of obesity is anticipated to foster the expansion of the lumbosacral radicular pain market in the coming years. Obesity is a medical condition defined by an excessive accumulation of body fat, typically when the body mass index reaches 30 or higher, which elevates the likelihood of various health issues. The surge in obesity is fueled by inactive lifestyles and prevalent consumption of processed foods, as contemporary work environments increasingly entail extended periods of sitting and desk-bound activities, while readily available high-calorie, low-nutrient foods have become widespread in developed nations. Increased obesity directly contributes to a higher occurrence of lower back and leg pain resulting from compressed nerve roots, given that surplus body weight exerts additional mechanical strain on the lumbar spine and adjacent structures, causing nerve compression and inflammation. For instance, in May 2025, according to the Office for Health Improvement and Disparities, a UK-based government body, an estimated 64.5% of adults aged 18 and over in England were classified as overweight or living with obesity from 2023 to 2024, an increase from 64.0% in 2022 to 2023. Consequently, the rising prevalence of obesity is a significant factor propelling the growth of the lumbosacral radicular pain market.

What Segments Are Included Within The Lumbosacral Radicular Pain Market?

The lumbosacral radicular pain market covered in this report is segmented –

1) By Treatment Type: Pharmacological Treatment, Non-Pharmacological Treatment, Interventional Procedures

2) By Route Of Administration: Oral, Topical, Injectable, Implantable

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

4) By End User: Hospitals, Specialty Clinics, Rehabilitation Centers, Homecare Settings

Subsegments:

1) By Pharmacological Treatment: Nonsteroidal Anti-Inflammatory Drugs, Opioids, Anticonvulsants, Antidepressants, Muscle Relaxants, Corticosteroids

2) By Non-Pharmacological Treatment: Physical Therapy, Exercise And Rehabilitation Programs, Chiropractic Care, Acupuncture, Cognitive Behavioral Therapy, Heat And Cold Therapy

3) By Interventional Procedures: Epidural Steroid Injections, Radiofrequency Ablation, Nerve Root Blocks, Spinal Cord Stimulation, Minimally Invasive Decompression, Intrathecal Drug Delivery Systems

Who Are The Top-Performing Companies In The Lumbosacral Radicular Pain Market In Recent Years?

Major companies operating in the lumbosacral radicular pain market are Medtronic plc, Boston Scientific Corporation, Nevro Corp., SPR Therapeutics, Saluda Medical Pty Ltd., Nalu Medical Inc., Abbott Neuromodulation, Stryker Corporation, Zimmer Biomet Holdings Inc., Globus Medical Inc., NuVasive Inc., Orthofix Medical Inc., B. Braun Melsungen AG, Teleflex Incorporated, Merit Medical Systems Inc., Avanos Medical Inc., Halyard Health Inc., Terumo Corporation, Baxter International Inc., Fresenius Kabi AG, Hikma Pharmaceuticals PLC, Pfizer CentreOne, Teva Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Lupin Limited, Zydus Lifesciences Ltd., Cipla Ltd., Dr. Reddy’s Laboratories Ltd., Amneal Pharmaceuticals Inc., Perrigo Company plc

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/lumbosacral-radicular-pain-global-market-report

Which Region Currently Holds The Largest Share Of The Lumbosacral Radicular Pain Market?

North America was the largest region in the lumbosacral radicular pain market in 2025. The regions covered in the lumbosacral radicular pain market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Lumbosacral Radicular Pain Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24591&type=smp

Browse Through More Reports Similar to the Global Lumbosacral Radicular Pain Market 2026, By The Business Research Company

Joint Pain Injections Market Report 2026

https://www.thebusinessresearchcompany.com/report/joint-pain-injections-global-market-report

Neuropathic Pain Market Report 2026

https://www.thebusinessresearchcompany.com/report/neuropathic-pain-global-market-report

Chronic Pain Market Report 2026

https://www.thebusinessresearchcompany.com/report/chronic-pain-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795